Cost of revenue · 2019–2025
Pharming Group cost of revenue
$45.5M+28.5% · FY2025
Pharming Group (PHAR) reported $45.5M in cost of revenue for fiscal 2025, +28.5% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $45.5M | +28.5% | Open → |
| FY20242024-12-31 | $35.4M | +40.4% | Open → |
| FY20232023-12-31 | $25.2M | +43.6% | Open → |
| FY20222022-12-31 | $17.6M | −16.9% | Open → |
| FY20212021-12-31 | $21.1M | −10.2% | Open → |
| FY20202020-12-31 | $23.5M | −1.6% | Open → |
| FY20192019-12-31 | $23.9M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +11.3%
Figures are reported under IFRS, in US dollars.
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pharming Group cost of revenue |url=https://companiesranked.com/en/company/pharming-group/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pharming Group cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/pharming-group/cost-of-revenueBibTeX
@misc{companiesranked-en-company-pharming-group-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Pharming Group cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pharming-group/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001828316-26-000015 · April 2, 2026
{{cite web |title=Pharming Group cost of revenue — 20-F (0001828316-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1828316/000182831626000015/pharm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.